{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T05:07:49Z","timestamp":1779512869098,"version":"3.53.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["S10OD030430"],"award-info":[{"award-number":["S10OD030430"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UM1TR004926"],"award-info":[{"award-number":["UM1TR004926"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019822","name":"Institute for Clinical and Translational Research, University of Maryland, Baltimore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA056739"],"award-info":[{"award-number":["R01DA056739"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2024-MSCRFD-6348"],"award-info":[{"award-number":["2024-MSCRFD-6348"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015326","name":"National Institutes of Health Common Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jconrel.2025.113880","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T10:49:45Z","timestamp":1748083785000},"page":"113880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Multi-modality imaging for precise intra-arterial delivery of mRNA, AAVs, and antibodies to the head and neck area in mice"],"prefix":"10.1016","volume":"384","author":[{"given":"Chengyan","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanda","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shriya","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Fadon-Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"Salemdawod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gulisashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorissa","family":"McDougall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslaw","family":"Janowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Walczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.113880_bb0005","series-title":"Global Cancer Observatory","year":"2023"},{"key":"10.1016\/j.jconrel.2025.113880_bb0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00432-018-2784-4","article-title":"Short-term intra-arterial infusion chemotherapy for head and neck cancer patients maintaining quality of life","volume":"145","author":"Aigner","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.113880_bb0015","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1002\/cncr.31675","article-title":"Suicide risk among cancer survivors: head and neck versus other cancers","volume":"124","author":"Osazuwa-Peters","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2025.113880_bb0020","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1038\/s41598-021-85820-3","article-title":"Intra-arterial transplantation of stem cells in large animals as a minimally-invasive strategy for the treatment of disseminated neurodegeneration","volume":"11","author":"Malysz-Cymborska","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.113880_bb0085","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1007\/s00259-019-04347-y","article-title":"PET imaging of distinct brain uptake of a nanobody and similarly-sized PAMAM dendrimers after intra-arterial administration","volume":"46","author":"Lesniak","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jconrel.2025.113880_bb0100","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2967\/jnumed.118.218792","article-title":"A distinct advantage to intraarterial delivery of (89)Zr-bevacizumab in PET imaging of mice with and without osmotic opening of the blood-brain barrier","volume":"60","author":"Lesniak","year":"2019","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2025.113880_bb0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jjco\/hyv151","article-title":"Intra-arterial chemoradiotherapy for head and neck cancer","volume":"46","author":"Homma","year":"2016","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.113880_bb0030","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jfma.2019.12.002","article-title":"The impacts of intra-arterial chemotherapy on head and neck microvascular reconstruction","volume":"119","author":"Kuan","year":"2020","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.jconrel.2025.113880_bb0035","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00685642","article-title":"Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formation","volume":"37","author":"Los","year":"1995","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.113880_bb0040","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/1097-0347(200010)22:7<687::AID-HED8>3.0.CO;2-W","article-title":"Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients","volume":"22","author":"Robbins","year":"2000","journal-title":"Head Neck"},{"key":"10.1016\/j.jconrel.2025.113880_bb0045","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1200\/JCO.2005.03.168","article-title":"Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615","volume":"23","author":"Robbins","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.113880_bb0050","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.ijrobp.2010.01.011","article-title":"Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer","volume":"79","author":"Mitsudo","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jconrel.2025.113880_bb0055","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1007\/s00405-021-07121-9","article-title":"Therapeutic efficacy of selective intra-arterial chemoradiotherapy with docetaxel and nedaplatin for fixed bulky nodal disease in head and neck cancer of unknown primary","volume":"279","author":"Heianna","year":"2022","journal-title":"Eur. Arch. Otorrinolaringol."},{"key":"10.1016\/j.jconrel.2025.113880_bb0060","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.ijrobp.2023.11.031","volume":"118","author":"Homma","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jconrel.2025.113880_bb0065","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/cncr.24916","article-title":"Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: results of a randomized phase 3 trial","volume":"116","author":"Rasch","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2025.113880_bb0070","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41596-021-00634-x","article-title":"Hyperosmolar blood-brain barrier opening using intra-arterial injection of hyperosmotic mannitol in mice under real-time MRI guidance","volume":"17","author":"Chu","year":"2022","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2025.113880_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-014469","article-title":"Real-time MRI guidance for intra-arterial drug delivery in a patient with a brain tumor: technical note","volume":"12","author":"Zawadzki","year":"2019","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.jconrel.2025.113880_bb0080","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/0271678X15615875","article-title":"Predicting and optimizing the territory of blood-brain barrier opening by superselective intra-arterial cerebral infusion under dynamic susceptibility contrast MRI guidance","volume":"36","author":"Janowski","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2025.113880_bb0090","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1177\/0271678X17703888","article-title":"Overexpression of VLA-4 in glial-restricted precursors enhances their endothelial docking and induces diapedesis in a mouse stroke model","volume":"38","author":"Jablonska","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2025.113880_bb0095","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jconrel.2019.11.019","article-title":"Optimization of osmotic blood-brain barrier opening to enable intravital microscopy studies on drug delivery in mouse cortex","volume":"317","author":"Chu","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113880_bb0105","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3389\/fneur.2018.00921","article-title":"Real-time MRI guidance for reproducible hyperosmolar opening of the blood-brain barrier in mice","volume":"9","author":"Chu","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jconrel.2025.113880_bb0110","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.oooo.2021.11.007","article-title":"Intratumor hemodynamics using contrast-enhanced MRI in intra-arterial chemotherapy for head and neck cancer","volume":"133","author":"Ito","year":"2022","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.jconrel.2025.113880_bb0115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41577-019-0243-3","article-title":"Novel vaccine technologies for the 21st century","volume":"20","author":"Mascola","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.113880_bb0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/2051013613508729","article-title":"A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs","volume":"2","author":"Kallen","year":"2014","journal-title":"Ther. Adv. Vaccines"},{"key":"10.1016\/j.jconrel.2025.113880_bb0125","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2025.113880_bb0130","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.113880_bb0135","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJMc2032195","article-title":"Durability of responses after SARS-CoV-2 mRNA-1273 vaccination","volume":"384","author":"Widge","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.113880_bb0140","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41587-019-0247-3","article-title":"Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation","volume":"37","author":"Miao","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.113880_bb0145","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/acs.nanolett.6b03329","article-title":"Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy","volume":"17","author":"Oberli","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.113880_bb0150","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.molmed.2021.03.003","article-title":"Lipid nanoparticle-mediated delivery of mRNA therapeutics and vaccines","volume":"27","author":"Swingle","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2025.113880_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.8","article-title":"Lipid-based transfection reagents exhibit cryo-induced increase in transfection efficiency","volume":"5","author":"Sork","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2025.113880_bb0160","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.113880_bb0165","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jconrel.2016.01.001","article-title":"Adeno-associated virus (AAV) vectors in cancer gene therapy","volume":"240","author":"Santiago-Ortiz","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113880_bb0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12985-024-02286-1","article-title":"Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma","volume":"21","author":"Hadi","year":"2024","journal-title":"Virol. J."},{"key":"10.1016\/j.jconrel.2025.113880_bb0175","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/pgmj.2007.061994","article-title":"Gene therapy in head and neck cancer: a review","volume":"83","author":"Chisholm","year":"2007","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.jconrel.2025.113880_bb0180","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4103\/0971-6866.120811","article-title":"An overview of gene therapy in head and neck cancer","volume":"19","author":"Bali","year":"2013","journal-title":"Indian J. Hum. Genet."},{"key":"10.1016\/j.jconrel.2025.113880_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975803","article-title":"Immunogenicity and toxicity of AAV gene therapy","volume":"13","author":"Ertl","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.113880_bb0190","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.113880_bb0195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2025.113880_bb0200","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1056\/NEJMe058306","article-title":"Cetuximab and radiotherapy for head and neck cancer","volume":"354","author":"Posner","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.113880_bb0205","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1200\/JCO.21.02508","article-title":"Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: updated results of the phase III KEYNOTE-048 study","volume":"41","author":"Harrington","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.113880_bb0210","article-title":"Monoclonal antibodies for the treatment of squamous cell carcinoma: a literature review","volume":"6","author":"Tamimi","year":"2023","journal-title":"Cancer Rep. (Hoboken)"},{"key":"10.1016\/j.jconrel.2025.113880_bb0215","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1200\/JCO.2010.33.3591","article-title":"Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer","volume":"29","author":"Argiris","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.113880_bb0220","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ijrobp.2014.11.029","article-title":"Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusion","volume":"91","author":"Nyflot","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jconrel.2025.113880_bb0225","first-page":"136","article-title":"Bevacizumab inhibits angiogenic cytokines in head and neck squamous cell carcinoma: from gene to the protein","volume":"12","author":"Heydar","year":"2018","journal-title":"Int. J. Hematol. Oncol. Stem Cell Res."},{"key":"10.1016\/j.jconrel.2025.113880_bb0230","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1002\/cncr.27498","article-title":"A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III\/IVB head and neck squamous cell cancer","volume":"118","author":"Fury","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2025.113880_bb0235","first-page":"0186","article-title":"Imaging carotid plaque burden in living mice via hybrid semiconducting polymer nanoparticles-based near-infrared-II fluorescence and magnetic resonance imaging","volume":"6","author":"Xu","year":"2023","journal-title":"Research (Wash. DC)"},{"key":"10.1016\/j.jconrel.2025.113880_bb0240","doi-asserted-by":"crossref","DOI":"10.59717\/j.xinn-med.2023.100023","article-title":"Confinement-guided ultrasensitive optical assay with artificial intelligence for disease diagnostics","volume":"1","author":"Zhang","year":"2023","journal-title":"Innov. Med."},{"key":"10.1016\/j.jconrel.2025.113880_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20240010","article-title":"Advancements of non-invasive imaging technologies for the diagnosis and staging of liver fibrosis: present and future","volume":"5","author":"Huang","year":"2024","journal-title":"View"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:55:25Z","timestamp":1779512125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925005000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":49,"alternative-id":["S0168365925005000"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113880","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-modality imaging for precise intra-arterial delivery of mRNA, AAVs, and antibodies to the head and neck area in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113880","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113880"}}